Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
482 Deciphering the heterogeneity of B-cell checkpoint inhibitors within tertiary lymphoid structures: Implications for lung cancer immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
